The growing burden of diabetes mellitus in the US elderly population.

BACKGROUND The prevalence of diabetes mellitus is growing worldwide. Consequently, there has been increased emphasis on primary and secondary prevention of diabetes. To our knowledge, whether there have been actual improvements in outcomes in the last decade or so has not been documented in a nationally representative sample. METHODS We undertook this study to examine trends in rates of occurrence of diabetes and its complications in persons older than 65 years in the United States. National longitudinal analysis of Medicare claims and other Medicare program data for persons first diagnosed as having diabetes during 1994 (n=33 164), 1999 (n=31 722), or 2003 (n=40 058) were compared with 2 control groups of persons of approximately equal sample size who were not diagnosed as having diabetes, alternatively during 1994, 1999, or 2003 or for the entire period from 1994 to 1999 or from 1999 to 2004. The main outcome measures were death and complications of diabetes including cardiovascular, cerebrovascular, ophthalmic, renal, and lower extremity events. RESULTS The annual incidence of diabetes increased by 23% between 1994-1995 and 2003-2004, and prevalence increased by 62%. The mortality rate after diagnosis in persons having diagnosed diabetes decreased by 8.3% compared with that in the control groups. Complication rates among persons diagnosed as having diabetes generally increased or stayed the same compared with those in the control groups during 1994 to 2004 except for ophthalmic diseases associated with diabetes. Rates for some major complications were high; for example, the rate for congestive heart failure in the diabetes group during 1999 to 2004 was 475 per 1000 persons. In some cases, most notably renal events, including the most serious complications, there were increases in prevalence in both the diabetes and control groups. CONCLUSION The burden of financing and providing medical care for persons older than 65 in the United States having diagnosed diabetes is growing rapidly as a result of increased incidence and, especially, prevalence of diagnosed diabetes, decreased mortality, and overall lack of improvement in rates of complications in persons having diagnosed diabetes.

[1]  Michael J. Pencina,et al.  Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study , 2006, Circulation.

[2]  David M Nathan,et al.  Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus , 2002, Annals of Internal Medicine.

[3]  A. L'Abbate,et al.  Association between increased mortality and mild thyroid dysfunction in cardiac patients. , 2007, Archives of internal medicine.

[4]  F. L. Lucas,et al.  Temporal Trends in the Utilization of Diagnostic Testing and Treatments for Cardiovascular Disease in the United States, 1993–2001 , 2006, Circulation.

[5]  E. Vittinghoff,et al.  Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. , 2005, Archives of internal medicine.

[6]  L. Ghiadoni,et al.  Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[7]  J. Pankow,et al.  Apolipoprotein E and progression of chronic kidney disease. , 2005, JAMA.

[8]  Charles Maynard,et al.  Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. , 2003, Diabetes care.

[9]  B. Yawn,et al.  Identifying Persons with Diabetes Using Medicare Claims Data , 1999, American journal of medical quality : the official journal of the American College of Medical Quality.

[10]  M. Engelgau,et al.  Changes in incidence of diabetes in U.S. adults, 1997-2003. , 2006, American journal of preventive medicine.

[11]  Betsy L Cadwell,et al.  Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. , 2004, Diabetes care.

[12]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[13]  Frank A Sloan,et al.  Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. , 2007, Archives of internal medicine.

[14]  N. Powe,et al.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. , 2000, The Journal of clinical endocrinology and metabolism.

[15]  J. Xue,et al.  Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? , 2005, Kidney international.

[16]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[17]  K. A. Thomas,et al.  Measures of Disease Control in Medicare Beneficiaries with Diabetes Mellitus , 1999, Journal of the American Geriatrics Society.

[18]  L. Ghiadoni,et al.  Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  Haiqing Zhang,et al.  Subclinical hypothyroidism , 2009 .

[20]  A. Fraser,et al.  Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  Ralph B D'Agostino,et al.  Trends in cardiovascular complications of diabetes. , 2004, JAMA.

[22]  Peter O'Leary,et al.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. , 2005, Archives of internal medicine.

[23]  A. Brett Can We Prevent Type 2 Diabetes , 2001 .

[24]  A. Morris,et al.  The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[25]  T. Buchanan (How) Can We Prevent Type 2 Diabetes? , 2007, Diabetes.

[26]  C. Palombo,et al.  Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. , 2004, The Journal of clinical endocrinology and metabolism.

[27]  Giuseppe Remuzzi,et al.  Nephropathy in Patients with Type 2 Diabetes , 2002 .

[28]  J. Leahy Mortality Trends in Men and Women with Diabetes, 1971 to 2000 , 2008 .

[29]  B. Virnig,et al.  The Medicare-HMO revolving door--the healthy go in and the sick go out. , 1997, The New England journal of medicine.

[30]  E. Ritz,et al.  Nephropathy in patients with type 2 diabetes mellitus. , 1999, The New England journal of medicine.

[31]  S. Haffner,et al.  Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. , 1999, Archives of internal medicine.

[32]  M. Alevizaki,et al.  High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism? , 1998, European journal of endocrinology.

[33]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[34]  J. Weaver,et al.  The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.

[35]  J. Franklyn,et al.  Thyroid function and mortality in patients treated for hyperthyroidism. , 2005, JAMA.

[36]  M. Harris Medical Care for Patients with Diabetes: Epidemiologic Aspects , 1996, Annals of Internal Medicine.

[37]  J. Mehlsen,et al.  Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. , 2002, Thyroid : official journal of the American Thyroid Association.

[38]  E. McGlynn,et al.  The quality of health care delivered to adults in the United States. , 2003, The New England journal of medicine.

[39]  J. Franklyn,et al.  Association between serum free thyroxine concentration and atrial fibrillation. , 2007, Archives of internal medicine.

[40]  G. Meneilly,et al.  Diabetes in elderly adults. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[41]  L. Ghiadoni,et al.  Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[42]  J. Crews,et al.  Public health and aging. , 2003, American journal of public health.

[43]  E. Mazzaferri Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .

[44]  L. Melton,et al.  Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes , 1998, Diabetes Care.

[45]  A. de Leiva,et al.  Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? , 1998, Diabetologia.

[46]  J. Leahy,et al.  Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002Saaddine JB, Cadwell B, Gregg EW, et al (Centers for Disease Control and Prevention, Atlanta, Ga) Ann Intern Med 144:465–474, 2006§ , 2007 .